Jaargang 28 (2008)
Nummer: 02
Artikel: 97

Pictogram

DT-28-02-97.pdf 522.04 KB 166 downloads

Motiverende gespreksvoering bij patiënten met schizofrenie ...

Samenvatting

Therapieontrouw aan antipsychotische medicatie is een frequent voorkomend probleem bij patiënten met schizofrenie of een aanverwante stoornis. Het zorgt bij hen voor een drie tot vijf maal grotere kans op terugval, opname en suïcide. Er bestaat een aantal interventies die trachten de therapietrouw bij deze doelgroep te verhogen, maar geen daarvan is eenduidig effectief gebleken. Motiverende gespreksvoering blijkt effectief te zijn om verslaafde patiënten tot verandering te bewegen. Hoewel de wetenschappelijke evidentie op dit gebied nog niet eenduidig is, lijkt de methodiek ook nuttig om patiënten met schizofrenie te verleiden tot betere therapietrouw. Er lopen op dit moment verschillende onderzoeken om dat uit te wijzen. In dit artikel wordt een kort overzicht gegeven van motiverende gespreksvoering, de aanpassingen waaraan kan worden gedacht bij patiënten met psychotische stoornissen, en aan de hand van twee casussen wordt gedemonstreerd hoe de techniek kan worden toegepast om bij deze doelgroep een betere therapietrouw te bereiken.

Summary

Non-adherence to antipsychotic medication in patients with schizophrenia and related psychotic disorders is a frequently observed problem. Within this group of patients, non-adherence is associated with three to five times higher rates in relapse, admission and suicide. Several therapeutic interventions have been tried to improve medication adherence, but so far none has shown a robust effect. Motivational interviewing has proven its effectiveness in changing addictive behaviour. This method also appears to be useful to improve medication adherence in schizophrenic patients. So far however, research has not yet provided unambiguous support for this, and more research in this topic is conducted at present. This article presents an overview on motivational interviewing, adaptations that may be useful for patients with psychotic disorders, and concludes with two case examples on how motivational interviewing can be used to increase medication compliance within this group of patients.

Referenties

Allsop, S. (2007). What is this thing called motivational interviewing? Addiction, 102, 343-345.

Appelo, M. (2007). Socratisch Motiveren. Amsterdam: Uitgeverij Boom.

Ballack, A.S. & DiClemente, C.C. (1999). Treating substance abuse among patients with schizophrenia. Psychiatric Services, 50, 75-80.

Barkhof, E., De Haan, L., Meijer, C.J., Fouwels, A.J., Keet, I.P.M., Hulstijn, K.P., Schippers, G.M., & Linszen, D.H. (2006). Motivational interviewing in psychotic disorders. Current Psychiatry Reviews, 2, 207-213.

Bebbington, P.E. (1995). The content and context of compliance. International Clinical Psychopharmacology, 9, 41-50.

Brown, J.M. & Miller, W.R. (1993). Impact of motivational interviewing on participation and outcomes in residential alcoholism treatment. Psychology of Addictive Behaviors, 211-218.

Cramer, J.S. & Rosenheck, R. (1998). Compliance with medication regimes for mental and physical disorders. Psychiatric Services, 49, 196-201.

Dixon, L.B. & Lehman, A.F. (1995). Family interventions for schizophrenia. Schizophrenia Bulletin, 21, 631-643.

Dolder, C.R., Lacro, J.P., Leckband, S., & Jeste, D.V. (2003). Interventions to improve antipsychotic medication adherence: review of recent literature. Journal of Clinical Psychopharmacology, 23, 389-399.

Fenton, W.S., Blyer, C., & Heinssen, R.K. (1997). Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin, 23, 637-651.

Gray, R., Wykes, T., Edmonds, M., Leese, M., & Gournay, K. (2004). Effect of a medication management training for nurses on clinical outcomes for patients with schizophrenia. British Journal of Psychiatry, 185, 157-162.

Gray, R., Leese, M., Bindman J., Becker T., Burti, L., David, A., Gournay K., Kikkert, M., Koeter, M., Puschner, B., Schene, A., Thornicroft, G., & Tansella, M.(2006) Adherence therapy for people with schizophrenia: European multicentre randomised controlled trial. British Journal of Psychiatry, 189, 508-514.

Hawton, K., Sutton, L., Haw, C., Sinclair, J., & Deeks, J.J. (2005). Schizophrenia and suicide: systematic review of risk factors. British Journal of Psychiatry, 87, 9-28.

Hettema, J., Steele, J., & Miller, W.R. (2005). Motivational Interviewing. Annual Review of Clinical Psychology, 1, 91-111.

Hofer, E., Amering, M., Windhaber, J., Wancater, M., & Eberstaller, M. (2001). Does psychoeducation change the concept of illness of schizophrenic patients. Psychiatr Prax, 28, 287-291.

Hudson, T.J., Owen, R.R., Thrush, C.R., Han, X., Pyne, J.M., Thapa, P., & Sullivan, G. (2004). A pilot study of barriers to medication adherence in schizophrenia. Journal of Clinical Psychology, 65, 211-216.

Kampman, O. & Lehtinen, K. (1999). Compliance in psychoses. Acta Psychiatrica Scandinavica, 100, 167-175.

Kane, J.M. (2006). Utilization of long-acting antipsychotic medication in patient care. CNS Spectrums, 11(12 Suppl 14), 1-7.

Keith, S.J. & Kane, J.M. (2003). Partial compliance and patient consequences in schizophrenia: our patients can do better. Journal of Clinical Psychiatry, 64(11), 1308-1315.

Kemp, R.A. & David, A.S. (1995). Insight and adherence to treatment in psychotic disorders. British Journal of Psychiatry, 54, 222-227.

Kemp, R., Hayward, P., Applewhaite, G., Everitt, B., & David, A. (1996). Compliance therapy in psychotic patients: randomised controlled trial. British Medical Journal, 213, 345-349.

Kemp, R., Kirov, G., Everitt, B., Hayward, P., & David, A. (1998). Randomised controlled trial of compliance therapy: 18 month follow-up. British Journal of Psychiatry, 172, 413-419.

Lange, A. (1976). Judo, oftewel het niet trekken aan cliënten. Tijdschrift voor Psychotherapie, 2(5), 179-194.

Lambert, M., Conus, P., Eide, P., Mass,R., Karow, A., Moritz, S., Golks, D., & Naber, D. (2004). Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. European Psychiatry, 19(7), 415-422.

Lee, S. (2005). Experience of social stigma by people with schizophrenia in Hong Kong. British Journal of Psychiatry, 186, 153-157.

Lincoln, T.M., Wilhelm, K., & Nestoriuc, Y. (2007). Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: a meta-analysis. Schizophrenia Research, 96, 232-245.

Maneesakorn, S., Robson, D., Gournay, K., & Gray, R. (2007). An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand, Journal of Clinical Nursing, 16, 1302-1312.

Marcus, S.C. & Olfson, M. (2008). Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia. Schizophrenia Bulletin, 34, 173-180.

Martino, S., Carroll, K., Kostas, D., Perkins, J, & Rounsaville, B. (2002). Dual diagnosis motivational interviewing: a modification of motivational interviewing for substance-abusing patients with psychotic disorders. Journal of Substance Abuse Treatment, 23, 297-308.

McDonald, H.P., Garg, A.X., & Haynes, R.B. (2002). Interventions to enhance patient adherence to medication prescriptions. JAMA, 288, 2868-2879.

McEvoy, J.P., Lieberman, J.A., Stroup, T.S., Davis, S.M., Meltzer, H.Y., Rosenheck, R.A., Swartz, M.S., Perkins, D.O., Keefe, R.S., Davis, C.E., Severe, J., & Hsiao, J.K. (2006). Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. American Journal of Psychiatry, 163(4), 563-565.

McGlashan, T.H., Levy, S.T., & Carpenter, W.D. (1975). Integration and sealing over: clinically distinct recovery styles from schizophrenia. Archives of General Psychiatry, 32, 1269-1272.

Miller, W.R. & Rollnick, S. (2002). Motivational Interviewing; preparing people for change. New York, London: The Guilford Press.

Miller, W.R. & Wilbourne, P.L. (2002). Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction, 97, 265277.

Nasrallah, H.A. (2007). The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial. Journal of Clinical Psychiatry, 68(Suppl 1), 5-11.

O’Donnel, C., Donohoe, G., Sharkey, L., Owens, N., Migone, M., Harries, R., et al. (2003). Compliance Therapy: a randomised controlled trial in schizophrenia. British Medical Journal, 327, 834-836.

Prochaska, J.O. & DiClemente, C.C. (1982). Transtheoretical therapy: toward a more integrative model of change. Psychotherapy: Theory, Research, and Practice, 19, 276-288.

Robinson, D.G., Woerner, M.G., Alvir, J.M.J., Bilder, R.M., Hinrichsen, G.A., & Lieberman, J.A. (2002). Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophrenia Research, 57, 209-219.

Rummel-Kluge, C., Pitschel-Waltz, G., Bäuml, J., & Kissling, W. (2006). Psycho-education in schizophrenia – results of a survey of all psychiatric institutions in Germany, Austria and Switzerland. Schizophrenia Bulletin, 32, 765-775.

Rusch, N. & Corrigan, P.W. (2002). Motivational interviewing to improve insight and treatment adherence in schizophrenia. Psychiatric Rehabilitation Journal, 26, 23-32.

Sevy, S., Nathanson, K., Visweswaraiah, H., & Amador, X. (2004). The relation between insight and symptoms in schizophrenia. Comprehensive Psychiatry, 45, 16-19.

Smith, D.E., Heckemeyer, C.M., Kratt, P.P., & Mason, D.A. (1997). Motivational interviewing to improve adherence to a behavioral weight-control program for older obese women with NIDDM. A pilot study. Diabetes Care, 20, 52-54.

Staring, A.B.P., Mulder, C.L., Van der Gaag, M., Selten, J.P., Loonen, A.J.M., & Hengeveld, M.W. (2006). Understanding and improving treatment adherence in patients with psychotic disorders; a review and a proposed intervention. Current Psychiatry Reviews, 2, 487-494.

Thomas, P. (2007). The stable patient with schizophrenia–from antipsychotic effectiveness to adherence. Eur Neuropsychopharmacol, 17(Suppl 2), 115-122.

Torrey, E.F. & Zdanowicz, M. (2001). Outpatient commitment: what, why and for whom. Psychiatric Services, 52, 337-341.

Treasure, J.L., Katzman, M., Schmidt U., Troop, N. Todd, G., & Silva, P. da (1999). Engagement and outcome in the treatment of bulimia nervosa: first phase of a sequential design comparing motivation enhancement and cognitive behavioural therapy. Behaviour Research and Therapy, 37, 405-418.

Ucok, A., Polat, A., Cakir, S., & Genc, A. (2006). One year outcome in first episode schizophrenia; predictors of relapse. European Archives of Psychiatry and Clinical Neuroscience, 256, 37-43.

Valenstein, M., Ganoczy, D., McCarthy, J.F., Myra Kim, H., Lee, T.A., & Blow, F.C. (2006). Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. Journal of Clinical Psychiatry, 67, 1542-1550.

Weiden, P., Aquila, R., & Standard, J. (1996). Atypical antipsychotic drugs and long-term outcome in schizophrenia. Journal of Clinical Psychiatry, 57(Suppl. 11), 53-60.

Weiden, P., Burkholder, P., Schooler, N., Weedon, J., Uzenoff, S., & Turkington, D. (2007). Improving Antipsychotic Adherence in Schizophrenia: A Randomized Pilot Study of a Brief CBT Intervention. Program and abstracts of the 160th Annual Meeting of the American Psychiatric Association; May 19-24, 2007; San Diego, California. Abstract NR803.

Weiden, P., Dixon, L., Frances, A., Appelbaum, P., Haas, G., & Rapkin, B. (1991). Neuroleptic noncompliance in schizophrenia. In: C.A. Tamminga & S.C. Schulz (red.). Advances in neuropsychiatry and psychopharmacology: Schizophrenia Research (pp. 286-296). New York: Raven Press.

Weiden, P.J., Kozma, C., Grogg, A., & Locklear, J. (2004). Partial compliance and risk of rehospitalization among California medicaid patients with schizophrenia. Psychiatric Services, 55, 886-891.

Weiss, K.A., Smith, T.E., Hull, J.W., Piper, A.C., & Huppert, J.D. (2002). Predictors of risk of nonadherence in outpatients with schizophrenia and other psychotic disorders. Schizophrenia Bulletin, 28(2), 341-349.

White, H.R., Morgan, T.J., Pugh, L.A., Celinska, K., Labouvie, E.W., & Pandina, R.J. (2006). Evaluating two brief substance-use interventions for mandated college students. Journal of Studies on Alcohol, 67, 309-317.

Zweben, A. & Zuckoff, A. (2002). Motivational Interviewing and Treatment Adherence. In: W.R. Miller & S. Rollnick (red.). Motivational Interviewing; preparing people for change (pp. 299-319). New York, London: The Guilford Press.

Zygmunt, A., Olfson, M., Boyer, C.A., & Mechanic, D. (2002). Interventions to improve medication adherence in schizophrenia. American Journal of Psychiatry, 159, 1653-1664.

Pictogram

DT-28-02-97.pdf 522.04 KB 166 downloads

Motiverende gespreksvoering bij patiënten met schizofrenie ...